Overdiagnosis: its rise, causes, and possible cures Professor Paul Glasziou NHMRC Australia Fellow Bond University Private Healthcare.

Slides:



Advertisements
Similar presentations
How do we achieve cost effective cancer treatments in the UK? Professor Peter Littlejohns Department of Public Health and Primary Care.
Advertisements

John N. Lavis, MD, PhD Professor and Canada Research Chair in Knowledge Transfer and Exchange McMaster University Program in Policy Decision-Making McMaster.
Living well with dementia: more timely diagnosis and early intervention Louise Robinson Professor of Primary Care and Ageing RCGP National Clinical Champion.
Economic Impact of a Sedentary Lifestyle. Exercise and Body Composition The health care costs associated with obesity treatment were estimated at $117.
Case studies: personal genetic profiling and body imaging Professor Nikolas Rose Martin White Professor of Sociology BIOS Centre for the Study of Biomedicine.
Prostate Cancer Support Federation Charity Nº: We have no national screening programme for the most common cancer in men and the only test we.
Gender and its Impact on Men’s Health 2nd Year Sex, Gender and Medicine Seminar Rob McLachlan Deputy Director of Endocrinology Monash Medical Centre Australia.
Health care spending- private health insurance in perspective Australian Health Insurance Association Conference, 2 November 2006.
NCI Designation: Expanding Science and Promoting Health in the Region Name Title, Company Date.
Prostate Cancer Crisis: Imaging is the Solution Faina Shtern, MD President, AdMeTech Foundation.
1 Alzheimer’s Disease Who is Affected? Presented by Maria C. Carrillo, Ph.D. Alzheimer’s Association December 2010.
Hypertension and The Kidney Update: Clinical Trials Paul J. Scheel, Jr., M.D. Director, Division of Nephrology The Johns Hopkins University School of Medicine.
4.6 Assessment of Evaluation and Treatment 2013 Analytic Lung Cancer.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
On Health Care and Women in the US Economics Perspective.
The Impact of Employee Wellness on 4-Year Healthcare Costs May 14, 2009 Brian Day, Ed.D Health Plan Informatics.
Rankings: What do they matter, what do they measure? Anne McFarlane August 18, 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Screening PHIL THIRKELL. What is screening?  A process of identifying apparently healthy people who may be at risk of a disease or condition  Identify.
© Open University Press, 2004 Overview Prevention and screening Psychological predictors of screening The ethics and usefulness of screening? Psychological.
PROSTATE CANCER AND SMOKING Kym Hickey MBBS, MPH Repatriation Medical Authority, Australia.
Rays Awareness: Apps to Promote Sun Safety November 8, 2011 Robert Burchard and Julie Kunrath, EPA’s Office of Air and Radiation Julie Kocher, EPA’s Office.
Imaging in headache patients “Incidentalomas” Giles Elrington Barts & The London
Prostate Cancer Screening 2012 Paul L. Crispen, MD Department of Surgery University of Kentucky.
Colon Cancer Screening Alison Little, MD, MPH Medical Director, Medicaid.
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
Promoting Shared Decision Making Jack Fowler Informed Medical Decisions Foundation.
Decision Support as a Clinical Skill Module III: Decision aids designed for specific decisions Last update: September 2008.
Indianapolis Discovery Network for Dementia Forecasting the Future Impact of Early Detection and Management Program for Alzheimer.
SYDNEY MEDICAL SCHOOL HEALTH LITERACY: A RESEARCH PERSPECTIVE Kirsten McCaffery Associate Professor School of Public Health
Clare Rogers Consultant Breast Surgeon Doncaster and Bassetlaw Hospitals.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
Thomas B. Newman, MD, MPH Andi Marmor, MD, MSEd October 21, 2010.
Barriers and Facilitators to Clinical Trial Research in Australia Google images Michael Friedlander.
Community Oncology Conference Thursday April 23 rd, 2015.
Session Fertility and Pregnancy FL-BBM Specific questions Risk of premature ovarian failure Ability to become pregnant Safety of pregnancy.
JCUH NICE MSCC Guidelines Compliance audit Ruth Mhlanga Senior Specialist Physiotherapist Oncology and Haematology.
Name Institution Date. Description of the Target Population The target population for this study are the African- American population aged between
Genomic Health, Inc. Yuko Soneoka, Ph.D., J.D. Senior Corporate Counsel, IP Director of Intellectual Property January 31, 2013.
Commissioning the right COPD care for Londoners 7 November 2011 Royal College of Physicians.
HW215: Models of Health & Wellness Unit 7: Health and Wellness Models Geo-political Influences.
 2012 Johns Hopkins Bloomberg School of Public Health Joanna Cohen, PhD Director, Institute for Global Tobacco Control Bloomberg Professor of Disease.
Prostate Cancer Coalition of NC A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and.
Clinical Writing for Interventional Cardiologists.
+ Role of Industry in Clinical Care, Research, and Education.
The Relative Contribution of Prepregnancy Overweight and Obesity, Gestational Weight Gain, and IADPSG-Defined Gestational Diabetes Mellitus to Fetal Overgrowth.
Senior Statistician Per-Henrik Zahl, MA MD PhD
Screening 15. May BMJ 2003; 327: ”To ask about the ethics of screening, generally aimed to make healthier people healthier, sounds, if.
The Gender Gap: Health Care Disparities between Men and Women By Maria Psilis.
Chronic pelvic pain Journal Club 17 th June 2011 Dr Claire Hoxley (GPST1) Dr Harpreet Rayar (GPST2)
European Health Forum Gastein Workshop International Quality Comparisons 6 October 2005 "Measuring the patient's perspective: Current and future work in.
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
1 ECPC PAPER ON BLADDER CANCER FRANCESCO DE LORENZO Brussels, 20 April 2016.
Pre Diabetes Paul Westcar GP/Diabetes Lead Newbury and District CCG.
NHS Health Check programme An opportunity to engage 15 million people to live well for longer Louise Cleaver National Programme Support Manager.
Evan Klass, MD, FACP Associate Dean, Statewide Initiatives Director, Project ECHO-Nevada Pre-Gestational Diabetes: A Public Health Growth Industry.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
PSA Consensus and The Prostate Cancer Risk Management Programme Karen Stalbow, Prostate Cancer UK Dr Ali Cooper, Prostate Cancer UK Annual Conference 2016.
A proposed process for participatory decision on standards of care Daniel Tarantola, M.D., The University of New South Wales, Sydney, Australia IAS Conference,
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Second Preventing Overdiagnosis Conference September 15-17, Oxford UK
is radiographer chest x-ray reporting cost-effective?
Macmillan Next Steps Cancer Rehabilitation
an Employee Assistance Program (EAP)
Understanding Risk Scoring
Help Your Team Members Invest in Their Health
IDENTIFYING PRIORITY HEALTH ISSUES
MULTIDISCIPLINARY (MDT) APPROACH TO CLINICAL CARE MODEL FOR EFFECTIVE AND BEST EVIDENCE PATIENT CARE DR EZEKIEL ALAWALE MBBS, FWACS, FRCS(I), JCPTGP, GP.
Evidence Based Care & Resource Stewardship
Family History to Promote Individual Health
Presentation transcript:

Overdiagnosis: its rise, causes, and possible cures Professor Paul Glasziou NHMRC Australia Fellow Bond University Private Healthcare Australia Conference 2015

My Background: Researcher & GP

Growth in health care spending: Most is more and better (hospital) services More, and expanded 1. Usage of Tests 2. Usage of Treatments 3. Definitions of Disease (Overdiagnosis)

Medical advances increase Life Expectancy by 3 Months/Year

Types of Overdiagnosis A. Over-detection, e.g, cancer screening, incidental MRI findings, etc B. Expanded definitions, e.g, Diabetes, CKD, ADHD, C. Medicalization, e.g, “female sexual dysfunction”, hypotrichosis,

A. Overdetection: thyroid cancer Thyroid cancer tripled in 25 years; no more deaths

A. Overdetection: 4 cancers An epidemic of diagnosis, not an epidemic of cancer! Prostate Cancer Thyroid Cancer Breast Cancer Melanoma Source: AIHW

Incidental findings with MRI of head Prevalence (%)NNS Arachnoid cyst Aneurysm Meningioma CCM AVM0.052,000 Low grade glioma0.052,000 Victims of Modern Imaging Technology BMJ 2009;339:b3016 Frequency of incidental findings with MRI of head: a meta-analysis For most, treatment is not needed or is harmful. SIGN Guidelines suggest: “DO NOT do MRI unless …”

Incidentalomas in MRI of spine Jensen MC, NEJM, 1994 Disc protrusion in 24 year old with no back pain

Too much testing? “A normal person is someone who has not had enough tests” - Dean at John Hopkins Medical School

B. Expanding definitions of Diabetes US Prevalence by ageChange of Definition 2003 ADA update Impact of Definition Changes on: Trial interpretation, eg UKPDS Risk Scores, eg Framingham

A Tale of Two GDM Definitions  New criteria for diagnosing Gestational Diabetes (GDM) by International Association of Diabetes in Pregnancy Study Group (IADPSG)  Increase GDM diagnoses from 6% (WHO) to 18% (IADPSG)  Cost extra $US2.5 billion/year  Based on risk of adverse outcome  NO evidence treatment of new cases improve outcomes

Osteoporosis: Prevalence for changed definition M. Brooke Herndon et al. Health Aff 2007;26: ©2007 by Project HOPE - The People-to-People Health Foundation, Inc.

 Of 16 publications on 14 common conditions, 10 widened and 1 narrowed definitions.  Widen by 3 methods: (i) ‘‘pre-disease’’; (ii) lowering thresholds; (iii) earlier or new diagnostic methods.  None had rigorous assessment of potential harms of proposed changes.  The average proportion of members with industry ties was 75%; 12/16 chairs had ties. CONCLUSION: “research and policy attention might be directed at designing new processes for reviewing disease definitions, free of financial conflicts of interest and informed by rigorous analysis of benefits and harms.”

C. Medicalization Then you might have “Body Dysmorphic Disorder by Proxy”

Saving Normal Allen Frances, Chair DSM IV

Why does Overdiagnosis matter? Too much testing of well people and not enough care for the sick worsens health inequalities and drains professionalism, harming both those who need treatment and those who don’t.” Margaret McCartney, GP Glasgow, Author of “The Patient Paradox”.

What can we do? 1. Raise awareness 2. Inform patients of pros & cons 3. Guidelines for disease definitions 4. Invest in research & policy initiatives 5. …

1 Raise Awareness: #Overdiagnosis 2013 Dartmouth 2014 Oxford 2015 Washington (Launch in April, 6 Colleges)

2 Inform patients of pros and cons  Patients overestimate benefits and underestimate harms (of screening, treatments, etc)  Informing patients often dampens enthusiasm  Two processes  For individuals: shared decision making  For policy: community juries

3 Guidelines for disease definitions  Guidelines being developed by GIN, GRADE, WHO collaboration  1-day Meeting: August 2014  Position paper: 2015

4 Invest in research & policy initiatives “Our combined resources are a few $million, but for those promoting overdiagnosis it is $billions. It is a David and Goliath struggle.” Allen Frances Chair DSM IV

What can we do? 1. Raise awareness 2. Inform patients of pros & cons 3. Guidelines for disease definitions 4. Invest in research & policy initiatives 5. …